Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0018801 (heart failure)
 72,216 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The obvious effects of magnesium sulfate are noticed not only in ventricular tachyarrhythmia but also in supraventricular tachyarrhythmia (SVTA) which include paroxysmal supraventricular tachycardia (PSVT), chaotic atrial tachycardia (CAT), atrial fibrillation (AF) with rapid heart rate and nonparoxysmal junctional tachycardia (NPJT). This paper reports the effects of magnesium sulfate treatment in 25 cases of SVTA in a self-controlled before and after study. Among 10 cases of PSVT, 6 cases were treated by injection of 25% magnesium sulfate 5-10 ml. Except 2 cases with W-P-W and aberrant ventricular condition, the PS-VT were terminated immediately after half a dose of magnesium sulfate i.v. in 2 cases, other 2 cases were terminated by 5-10 min after a dose of magnesium sulfate i.v.. Some improvements were observed in these 4 cases. The rest 4 cases were prevented by 12 days' intravenous infusion of 1% magnesium sulfate 250 ml per day, 3 cases of them recovered. Three cases of CAT recovered within an hour to two days by infusion of 1% magnesium sulfate 250 ml. Four cases of AF with rapid heart rate were collected, even though it is difficult to determine whether it is due to overdose or inadequacy of digitalis. The heart rates were reduced by magnesium sulfate injection in those 4 cases. Eight cases of NPJT due to heart failure with digitalis intoxication recovered after infusion of 1% magnesium sulfate 250ml within 10 hours to two days. Finally, the mechanism of the effect of magnesium sulfate treatment in SVTA was discussed.
 ...
PMID:[Clinical effects of magnesium sulfate in the treatment of supraventricular tachyarrhythmia]. 236 46

The aim of the present study is to describe a case of complete temporary atrial standstill, following iv administration of flecainide during the course of an endocavitary electrophysiologic study (EES). The patient, 79 years old, with frequent anamnestic periods of flutter and atrial fibrillation, which was followed by heart failure and with conductory disturbances to the surface ECG (first degree A-V block and left axis deviation), underwent EES in order to evaluate the functional reserve of cardiac eccito-conduction. With electric programmed stimulation, during EES, we induced atrial flutter, with a cycle length of about 300 ms. The administration of flecainide, dosage 1.5 mg/Kg in 15 min, determined the complete disappearance of every atrial electric activity, confirmed by right and left (coronary sinus) atrial mapping, also after electrical stimulation, and the emergency of substitutional ventricular rhythm, to a frequency of about 30-40/min. After atropine, dosage 0.02 mg/Kg iv, we noted an increase in the frequency of added focus up to the value of about 110 b/min, without any evidence of atrial electric activity. With sulfate isoprenaline in venous infusion, dosing 2 gamma/min, we noted firstly a ventricular-atrial back-leading 1:1; and after an ectopic atrial rhythm, with a frequency of about 130 b/min. After 5 hours a sinusal rhythm appeared.
 ...
PMID:[A case of atrial paralysis during the use of intravenous flecainide acetate]. 251 41

A case of intoxication with 5 g of elemental iron (25 g of ferrous sulfate) in a 30-year old woman at 36 weeks gestation is reported. Deferoxamine treatment was given with a delay of 26 hours after ingestion. A healthy infant was delivered by cesarean section 31 hours following ingestion. Subsequently, the patient developed hepatic necrosis, coma and hemostatic dysfunction and expired in cardiac failure after two weeks. The fatal outcome supports the view that the potential lethal dose of iron is lower for adults than for children. This case also demonstrates that major hepatic dysfunction can be a prominent feature of adult cases of iron intoxication. It is not unequivocal that early institution of deferoxamine treatment would have had a significant influence on the outcome. However, taking into account the well-documented efficacy of the drug in children and that no major adverse fetal effects have been associated with deferoxamine treatment in pregnancy, we suggest such antidote therapy to be considered for prompt institution in similar cases.
 ...
PMID:Fatal iron intoxication in late pregnancy. 366 20

The hemodynamic effects of lumbar epidural anesthesia (LEA) were evaluated in 11 patients with severe preeclampsia. All patients were receiving magnesium sulfate upon entry into the study. Hemodynamic measurements were obtained before and after LEA, at delivery, and 2 hr postpartum. Lumbar epidural anesthesia significantly reduced mean arterial pressure from 121.4 mm Hg to 97.7 mm Hg, without altering cardiac index, pulmonary vascular resistance, central venous pressure (CVP), or pulmonary capillary wedge pressure (PCWP). There was a slight but statistically insignificant decrease in systemic vascular resistance from 1078 to 900.7 dynes X sec X cm-5. Cardiac index and left ventricular stroke work index were elevated in these patients, suggesting hyperdynamic left ventricular function. There was poor correlation between PCWP and CVP in several patients. We conclude that LEA may be used safely in severe preeclamptic patients and that pulmonary arterial catheters may help guide appropriate therapy in preeclamptic patients with cardiac failure or oliguria refractory to modest fluid challenges.
 ...
PMID:Severe preeclampsia: hemodynamic effects of lumbar epidural anesthesia. 394 Apr 67

Fifty-five patients with newly diagnosed, estrogen receptor negative, metastatic breast cancer were entered in a trial of mitoxantrone, 10 mg/m2 intravenous (IV), cyclophosphamide, 500 mg/m2 IV, and 5-fluorouracil, 1000 mg/m2 IV, which were given on day 1 of a 21-day treatment interval. This trial was designed to test the efficacy of substituting mitoxantrone for doxorubicin as part of a combination that has proved to be effective in inducing remission. The trial was also intended to evaluate the response of resistant disease and of stable metastatic disease to a combination of doxorubicin and vinblastine sulfate. The cardiotoxic potential of mitoxantrone was evaluated in all the patients by serial measurements of ejection fraction and by endocardial biopsy of the right ventricle. Patients who achieved a complete response or a partial response (with bone as the only site of disease) on the three-drug combination were continued on this treatment for 2 years, or for 1 year following a complete response, whichever was shorter or as cardiac monitoring permitted. Therapy with doxorubicin, 25 mg/m2/d for two days, followed by continuous infusion vinblastine sulfate, 1.4 mg/m2/d for four days, was given to all patients who progressed after two courses or were stable after six courses of three-drug therapy. The preliminary results from 50 patients show that 4 attained a complete response and 30 a partial response, giving a total response rate of 68%. The median duration of response was more than 7 months (range greater than 5 to greater than 15 months). One patient in complete remission relapsed after 8 months and failed reinduction therapy with doxorubicin-vinblastine sulfate. Myelosuppression, principally granulocytopenia, was the major side effect of cyclophosphamide-mitoxantrone-5-fluorouracil. Mild to moderate vomiting occurred in 76% of patients and alopecia in 88%. This therapy was discontinued in four patients because of a decreased cardiac ejection fraction and/or symptoms of heart failure. No cardiac biopsy score, however, has been greater than 1.0. These results suggest that a combination of cyclophosphamide-mitoxantrone-5-fluorouracil is effective in untreated, estrogen receptor negative, metastatic breast cancer and is comparable to the doxorubicin combination. Myocardial injury occurs with mitoxantrone, and a safe cumulative dose has yet to be established.
 ...
PMID:Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer. 638 62

Nine infants with episodic or continuous chaotic atrial rhythm (CAR) are presented. In addition to 3 or more different P-wave contours, atrial rates greater than 100 per minute, variable PP, RR, and PR intervals, and a discrete isoelectric baseline, findings included atrial rates that varied from a low of 50 to 120 to a high of 140 to 270 per minute, ventricular rates that varied from a low of 40 to 50 to a high of 180 to 270 per minute, and periodic sinus arrest with junctional escape rhythm. Except for the arrhythmia, all had a normal cardiac examination, ECG, chest x-ray film, and echocardiogram. Six infants were otherwise normal; one had an orbital rhabdomyosarcoma; one had neonatal asphyxia; and one had respiratory distress, bronchopulmonary dysplasia, and an intraventricular cerebral hemorrhage. The CAR persisted from 3 days to 20 months; it spontaneously reverted to normal sinus rhythm in 8 infants and persists in 1 infant at age 7 months. Digoxin (4 patients), propranolol hydrochloride (3 patients), quinidine sulfate (2 patients), and lidocaine (1 patient) did not alter the CAR. No patient had heart failure secondary to the CAR, although three also had episodes of sustained atrial tachycardia, which while present caused heart failure. All patients are functioning normally at home and have normal findings on cardiac examination and have normal ECGs at ages 3 to 38 months. Seven are in normal sinus rhythm, one has rare atrial premature contractions, and one has persistent CAR. We conclude that specific treatment was not necessary in these infants with CAR, except in those with associated sustained atrial tachycardia, which itself may cause heart failure.
 ...
PMID:Multifocal or chaotic atrial rhythm: report of nine infants, delineation of clinical course and management, and review of the literature. 711 Oct 53

To assess the response of the left ventricle to subcutaneously administered terbutaline sulfate, a proposed beta-2 selective agonist, we evaluated 12 patients who had suffered previous myocardial infarctions using equilibrium radionuclide angiography. Six patients (group 1) had normal global left ventricular ejection fraction at rest less than 0.49). All patients had a marked decline in end-diastolic volume and end-systolic volume with a significant (P less than 0.01) increase in ejection fraction after terbutaline injection. Cardiac output increased 30 percent in group 2 patients because of an increase in stroke volume, with little change in heart rate (plus or minus 3.1 beats per minute, P equals NS). Cardiac output increased 7 percent in the patients in groups 1, due primarily to an increase in heart rate in 7 beats per minute (+9 percent) with little change in stoke volume. Systemic vascular resistance decreased significantly more in the patients with compensated heart failure than the subjects in group 1 (342 plus or minus 84 vs 90 plus or minus 35 dynes-sec cm(-5), P less than 0.05). We conclude that terbutaline exerts its most beneficial effect on the left ventricle in patients with depressed resting global function, and may prove to be a useful agent in the treatment of congestive heart failure.
 ...
PMID:Left ventricular size and function after subcutaneous administration of terbutaline. 722 28

The effect of terbutaline sulfate on left ventricular size and performance was studied by M-mode echocardiography in pregnant women with premature labor. Patients with uterine activity initiated during either oxytocin challenge testing or induction of labor served as a comparison group. During terbutaline therapy, heart rate, ejection fraction, and cardiac output increased significantly. End-diastolic volume and systolic blood pressure (BP) were unchanged, and diastolic BP and end-systolic volume fell. No changes in echocardiographic or hemodynamic parameters were present during oxytocin-induced uterine activity. Terbutaline, as currently used to prevent premature labor, is a potent inotropic and chronotropic agent. Pulmonary edema accompanying terbutaline treatment is probably not due to cardiac failure.
 ...
PMID:Terbutaline and maternal cardiac function. 731 Sep 63

In a prospective study, 91 patients with penicillin-sensitive infective endocarditis (IE) were treated for two weeks with intramuscular (IM) penicillin G procaine, 1.2 million units every six hours, plus streptomycin sulfate, 500 mg IM every 12 hours. Viridans streptococci were isolated from 70 patients (77%); 21 patients (23%) had Streptococcus bovis infections. Eighteen patients (20%) had had symptoms of IE for three months or longer. Follow-up ranged from two months to 6.6 years. There were no relapses; mild vestibular toxic reactions occurred in two patients (2%). Two patients (2%) died--one of sudden-onset severe heart failure and one of cardiac arrest after aortic valve replacement. Twenty-six patients (19%) required cardiac valve replacement after completion of antimicrobial therapy. This therapy seems as efficacious as four weeks of parenteral antimicrobial therapy and is more cost-effective.
 ...
PMID:Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. 745 62

The case of a 63-year-old woman is presented to whom a barium sulfate enema was administered accidentally into the vagina. During inflation of the stop manchette a deep bilateral laceration of the vaginal mucosa occurred which was neglected initially. Thus, venous vessels were ruptured and the subsequent insufflation of the barium sulfate suspension resulted in a direct injection to the afferent veins and a peracute, massive pulmonary embolism. Within 1 min irreversible heart failure followed. The case differs in some aspects from two similar cases referred to in the literature, where death occurred 15 h and 3 days, respectively, after enema.
 ...
PMID:[Lethal barium sulfate embolism after accidental vaginal application (author's transl)]. 746 78


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>